Randomized phase 3 study of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (mCRC): The SALTO study of the Dutch Colorectal Cancer Group.
2016 ◽
Vol 34
(15_suppl)
◽
pp. 3640-3640
◽
Keyword(s):
Phase 3
◽
Keyword(s):
Keyword(s):
Keyword(s):